Amgen Inc. buy Piper Sandler
Start price
27.06.25
/
50%
€238.20
Target price
27.06.26
€280.34
Performance (%)
19.67%
Price
09.01.26
€280.30
Summary
This prediction is currently active. The prediction currently has a performance of 19.67%. Dividends of €4.76 are taken into consideration when calculating the performance. This prediction currently runs until 27.06.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 0.215% | 0.215% |
| iShares Core DAX® | 3.002% | 4.755% |
| iShares Nasdaq 100 | 2.966% | 0.363% |
| iShares Nikkei 225® | 5.606% | 4.528% |
| iShares S&P 500 | 2.312% | 1.811% |
Comments by Piper_Sandler for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $328.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat